Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

2020130 citationseditorialhybrid Open Access

Authors

Darius Armstrong‐James · NIHR Imperial Biomedical Research Centre

Jonathan Youngs · St George's, University of London

Tihana Bicanic · St George's, University of London

Alireza Abdolrasouli · Imperial College Healthcare NHS Trust

David W. Denning · Manchester Academic Health Science Centre

Elizabeth M. Johnson · Public Health England

Varun Mehra

Abstract

<b>Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infections</b>https://bit.ly/3feuGsQ

Topics & Keywords

Antifungal resistance and susceptibility

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Respiratory Journal

Volume 56, Issue 4, pp. 2002554-2002554

DOI: 10.1183/13993003.02554-2020

Field-Weighted Citation Impact: 2.81